HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Dec. 11, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA). Class Period: May 10, 2024 –…